Try our Advanced Search for more refined results
Life Sciences - November, 2006
104 articles
- Appeals Court Lets Biotech Patent Suit Proceed
- Drug-Coated Stents Face Further Scrutiny
- Eli Lilly & Co. Sued By 105 Plaintiffs Over Zyprexa
- Trial Starts In Pfizer's Norvasc Patent Dispute
- Court Refuses To Toss Claims Against Medtronic
- Drinker Biddle Merger Promises New Bankruptcy Force
- Merck Downplayed Vioxx Risks, Doctor Testifies
- Patent Lawyers Sweat As Supreme Court Hears Teleflex
- FDA Fines Red Cross For Blood-Safety Violations
- Cytosol Accosts Chubb For Insurance Money
- Wyeth, Others Face New Hormone Replacement Suit
- Federal Circuit Denies Amgen's Rehearing Request
- ITC To Review Smallpox Vaccine Ruling
- Court Rejects J&J Bid For Injunction In Amgen Case
- Judge Rules Vioxx Claims Should Be Tried Separately
- Cancer Vaccine Co. Files For Chapter 7
- State Attorney General Probes Off-Label Actiq Use
- Court Snubs Last-Ditch Motion In Univasc Suit
- Federal Circuit Boosts Impax In Aventis Patent Suit
- Teva To Pay Up To $70M To Settle With Pfizer
- FDA May Speed Drug Ad Review For Fee
- Bush Nominee For Family Planning Continues To Rankle
- New Cyberonics Chairman Probed For Backdating
- Appeals Court Revives Patent Suit Over Spinal Screws
- Another Republican Vows To Block FDA Confirmation
- Law Firm Profile: Epstein, Becker & Green
- Catheter Maker Settles Antitrust Suit
- Drinker Biddle Merger Creates Strong Securities Practice
- Drinker Biddle, Gardner Carton To Merge
- Drinker Biddle Merger To Boost Antitrust Practice
- Novo Nordisk Sues USPTO Over AERx Applications
- Pfizer Hardens Stance Over Chinese Viagra
- Alcon Sues Apotex To Block Generic Eye Drug
- Biovail CEO Tries To Muscle Back Into Bankruptcy Case
- Pharmaceutical Giants Face Wage And Hour Claims
- Drinker Biddle To Gain Top Health Care Group In Merger
- Federal Circuit Upholds Patent Ruling In Diprivan Case
- New Rules Addressing Physician Payment And Outpatient Procedures On Public Display
- Interference Proceeding Ordered In DNA Tech Spat
- Sales Rep Challenges Eli Lilly For Unpaid Overtime
- FDA Eyes Sanofi Antibiotic Over Safety Concerns
- Immune Response Settles Shareholder Suits
- Dusa Sues Chemical Co. Over Skin Treatment Patents
- Monsanto Fires Back At Solutia Noteholders
- Holders Name 13 Private Equity Firms In Antitrust Suit
- Generics Maker Settles Imitrex Suit With Glaxo
- Jury Gives Merck Another Vioxx Win
- U.S. Appeals Court Upholds Generic Zocor's Exclusivity
- Warner Chilcott Calls Truce Over Birth Control Drug
- Data Exclusivity Rules Rile Canadian Generics Makers
- Medical Device Co. Pokes Bayer With Suit Over Lancets
- Omnicare Settles Fraud Charges For $49.5M
- Companies Settle Patent Suit Over Vascular Product
- Synergetics Starts A Battle In Eye Surgery Patent War
- Boeing Deal Stalled In Wake Of Milberg Weiss Scandal
- Stryker Wins Second Round In Bout With Acumed
- Shire Unit Asserts Adderall Patents Against Andrx
- SeraCare Agrees To Shareholder's Chapter 11 Plan
- Crowell Snags Health & Employment Boutique
- Vioxx Class Action Approved In Quebec
- Metabolife Forks Over $56M In Ephedra Settlement
- Court Scraps Counterclaims Against J&J Unit
- Spectrum Settles With Glaxo Over Imitrex
- FDA To Up Postmarket Regulation Of Medical Devices
- FTC Probes Adderall Settlement Between Barr, Shire
- Law Firm Profile: Robins, Kaplan, Miller & Ciresi LLP
- Democrats Take Control, Look To Reform Drug Laws
- Hypertension Patients Join Feud Over Pfizer's Norvasc
- Privilege Concerns Over Disclosures To Independent Auditors
- Shareholders Rebel Against Connetics
- Jury Rejects Doctor's Claim Over Genentech Drug
- Abbott's Ultane Patent Declared Invalid
- Advocates Can Subpoena White House In Plan B Suit
- Pharma Stalls U.S., Korean Free Trade Talks
- Generic Allegra To Remain On The Market
- Pfizer Attacked Over Lipitor Licensing Pact
- Bradley Pharmaceuticals Derivative Action Dismissed
- Stryker CEO Says DOJ Should End Price-Fixing Probe
- Merck Riled In Tax Dispute With U.S. And Canada
- Martha Stewart's Co. To Settle ImClone Suit For $30M
- Teva Motions Denied In Patent Spat With Pfizer
- High Court Ask DOJ To Weigh In On Damages
- QLT Liable For Unfair Trade In Visudyne Litigation
- Has the Federal Circuit Said Enough to Save Its "Motivation, Teaching, Suggestion" Test?
- Law Firm Profile: Bromberg & Sunstein LLP
- Apotex' Antitrust Claims In Patent Case Approved
- FDA Warns Bausch & Lomb After Plant Inspection
- Antitrust Suit Claims Eisai Duped Patent Agency
- Pharmaceutical Giants, Consumers Spar As Trial Looms
- Eli Lilly Receives Subpoena Over Zyprexa
- CV Therapeutics Offers $13.5M In Settlement Agreement
- Law Firm Profile: Dechert LLP
- Court Denies J&J Unit's Motion In Spinal Screw Suit
- Warner Chilcott Hit With Suit Over IPO Prospectus
- Israeli Researchers Want ImClone To Pay Royalties
- CVS-Caremark Merger Creates Antitrust Complications
- Ortho-McNeil Faces More Suits Over Contraceptive
- Cyberonics Shareholder Pushes For Annual Meeting
- Genentech Backtracks In Synagis Dispute
- As Prices Are Slashed, Drug Makers Eye German Law
- Judge Trebles Invitrogen's Cash Award
- Amerigroup To Fight Back Against $144M Verdict
- Glaxo Agrees To Settle Paxil Litigation For $63.8M
- Supreme Court Denies Ferring B.V.'s Petition